European Archives - Page 671 of 1060 - European Medical Journal

Patient–Physician Discordance in the Assessment of Adherence to Inhaled Medication

Assessing adherence to inhaled medication remains a challenge in clinical practice. Self-reports, although subjective, are still considered one…

EAACI 2019 Interview: Meeting the EMJ Allergy & Immunology Editorial Board

One of the key benefits of attending congresses across the continent is the opportunity it gives us to talk directly with our Editorial Board.

Leukocyte Adhesion Deficiency Type 1: A Case Series and Review of the Literature

Leukocyte adhesion deficiency type-1 (LAD-1) is a rare primary immunodeficiency that is characterised by compromised neutrophil adhesion and…

“I Look Disgusting”: A Qualitative Enquiry into the Impact of Atopic Dermatitis on Quality of Life in Adults

Atopic dermatitis (AD) has been related to poorer health-related quality of life (HRQoL) in adults, but no qualitative research has been published…

The Intensity of Physical Activity in Asthmatic Children During Active Video Game Playing

Physical exercise is an important non-pharmacological component of clinical asthma control, especially in children. However, physical exercise can lead…

Hereditary Alpha-Tryptasaemia Due to TPSAB1 Gene Duplication is Associated with Multifocal Sclerotic Bone Disease

Hereditary alpha-tryptasaemia (HAT) affects 4–6% of the population and is caused by allelic replications tandem duplications of the alpha-tryptase encoding…

Natural Killer Cells and Their Role in Immunity

Natural killer (NK) cells are effector lymphocytes that play protective roles against both infectious pathogens and cancer.

IgE Signalling Repression by a Designer DNA Vaccine to Modulate Shrimp Hypersensitivity

Shellfish is one of the most common food allergens worldwide, causing frequent anaphylaxis in both paediatric and adult populations. Despite the…

HIV Co-Receptor Usage, Broadly Neutralising Antibodies, and Treatment

The discovery of a new generation of highly potent broadly neutralising antibodies (bnAb) has provided a new weapon in the fight against HIV-1.

Type 2 Diabetes Mellitus Reversed through White Adipose Tissue Targeting

A team of researchers from University of British Columbia, Vancouver, Canada, and the Karolinska Institute, Solna, Sweden, have produced findings showing…